Business Wire

CA-ARYAKA

23.3.2021 13:02:07 CET | Business Wire | Press release

Share
Aryaka’s Fifth Annual Global State of the WAN Report Reveals Network Insights From 1,350 Global Enterprises

Aryaka® , the leader in fully managed Cloud-First WAN solutions, today published its fifth annual 2021 State of the WAN report, the industry’s foremost survey into global SD-WAN and SASE planning. Key trends identified in this year’s report include:

  • Accelerating fusion of networking and security planning, with almost a third of enterprises stating that they are already deploying what they consider to be a secure access service edge (SASE) architecture
  • A hybrid work environment that will persist after the pandemic recedes, with over 80% stating that they expect over a quarter of workers to remain remote, and over two-thirds desiring flexibility between on-premises and remote deployments
  • Continued WAN and application growth, resulting in increased network complexity. The number of enterprises reporting they’re deploying over 500 distinct applications has grown to 46%. 37% of enterprises identify complexity as their number one network concern
  • 43% of enterprises identify application performance as an underlying driver for WAN transformation. However, WAN transformations have slowed this year due to the pandemic
  • Over 70% of enterprises intend to move to managed services versus just 18% who prefer the autonomy of a do-it-yourself WAN solution

"Every year I look forward to Aryaka's high quality State of the WAN report for information on industry trends,” said Scott Raynovich, founder and chief analyst at Futuriom. “This year, the report reflects many of the same trends we are seeing at Futuriom, which include the ongoing integration of cloud-based networking services and security -- otherwise known as Secure Access Service Edge (SASE) -- as well as strong demand for virtualized networking solutions targeted at Work from Anywhere (WFA) and hybrid work environments. It's a good read!”

Year-on-Year Trends with Changing Challenges and Priorities

The WAN continues to extend its reach, with the number of enterprises connecting to over 100 inter-regional sites growing by 50%, from 19% in 2020 to 28% in 2021. This is coupled with continued application growth, with the number of enterprises stating that they’ve deployed over 500 distinct applications growing to 46%, compared to 32% in 2021. As evidence of collaboration traction, Zoom was identified as critical by 36% in 2021, up from 25% in 2020.

One finding that did not noticeably change year-on-year is complexity, which was identified by 36% of enterprises as their number one network issue. Interestingly, those who identified cost as a major issue grew to 20% in 2021 from 16% in 2020, a 25% increase. This may be attributed to cloud or MPLS cost concerns.

Overall, investment priorities did see recede in some areas, due to tactical pandemic concerns driving near-term planning. For example, only 17% of respondents plan to conduct an SD-WAN/SASE-driven network refresh this year versus 29% in 2020. However, combining this with remote access upgrades, a new entry at 22%, and security, at 21%, results in strong momentum going into 2021. In contrast, LTE/5G experienced growth from 24% in 2020 to 31% in 2021. Finally, VPN investment is at 31% this year versus 27% in 2020. Aryaka believes the new remote workforce, due to the pandemic, led to this VPN increase.

For actual deployment, managed services still reign supreme at 71%, versus 18% who are looking for a do-it-yourself (DIY) solution. Many enterprises are also further along the deployment lifecycle, with 26% evaluating SD-WAN this year, up from 22% in 2020. This increasing market maturity is reflected in a drop in identified barriers to SD-WAN adoption. Enterprises are less concerned that the WAN service won’t address application performance, coming in at 36% this year, versus 43% in 2020, with corresponding drops in SLA concerns, technology maturity, and lack of skills.

A Closer Look at SASE and the Rise of the Hybrid Workplace

Enterprise SASE deployment plans are accelerating, with 29% stating that they are already deploying what they consider to be a SASE architecture. Another 56% are planning to deploy a SASE architecture in the next 12-24 months. As part of a complete SASE architecture, the top capability identified was SD-WAN transport at 34%. And for deployment, over half state that they prefer a solution that includes technology from both their WAN vendor and security specialists, spanning across cloud and the edge.

When the pandemic hit, workers around the world migrated from their offices to their homes, a shift that will also impact future planning and investment throughout 2021. More than half (59%) of the respondents stated they expect 25-50% of their workers to remain remote, while 21% say they are planning for more than 50% of their workforce to continue working from home. Businesses are also prioritizing flexibility, with 63% stating that they consider the ability to quickly move resources between on-premises and remote to be very important.

“The fifth edition of the Global State of the WAN is bigger and better than ever, with survey inputs and insights from over 1350 Enterprises worldwide,” said Shashi Kiran, CMO of Aryaka. “On behalf of Aryaka Networks, I would like to express my gratitude to those who participated in this survey, and hope this serves as an excellent resource and guidebook for all those CIOs, network, cloud and security practitioners to leverage and proactively Plan their WAN™. Of particular interest are the trends focusing on SD-WAN and SASE deployments.”

Study Methodology

The Fifth Annual Global Aryaka 2021 State of the WAN study surveyed over 1350 global IT and network practitioners at enterprises spanning all verticals, headquartered in NA, APAC and EMEA. The survey asked respondents about their networking and performance challenges, priorities and their plans for 2021 and beyond.

Aryaka to Host 2021 The State of the WAN Webinars

Join us at the following dates/times for a lively panel discussion on the “Aryaka 2021 Global State of the WAN.” Regional observations will also be presented:

● North America

March 23, 1pm EST, 10am PST

Register Here

● EMEA

March 23, 3pm GMT

Register Here

● APAC

March 24, 930am IST, Noon Beijing

Register Here

This interactive format allows the panel of experts to deep dive into the Fifth annual State of the WAN report, which will include further analysis of the key findings driving digital transformation.

Download Report Here : https://www.aryaka.com/state-of-wan-2021/
Download Infographic Here : https://www.aryaka.com/docs/aryaka-state-of-the-wan-2021-infographic.pdf

Additional Resources:

  1. Aryaka Managed SD-WAN as-a-Service . This datasheet explains how the Aryaka SmartServices platform is built for the Cloud-First world. Specifically, this means there are no products to buy, and no inventory, deployment hassles, patches or configurations to worry about.
  2. Aryaka’s Cloud-First WAN for Dummies . This e-book explains everything you need to know about consuming your network as-a-Service, how to achieve fully integrated security, and how to make your network as easy as your cloud.

For more on Aryaka, please visit: https://www.aryaka.com/
Visit the Aryaka blog: https://www.aryaka.com/blog/
Follow Aryaka on Twitter: @AryakaNetworks
Visit Aryaka on LinkedIn: https://www.linkedin.com/company/aryaka-networks/

About Aryaka

Aryaka, the Cloud-First WAN company, brings agility, simplicity and a great experience to consuming the WAN-as-a-service for network and security. The company provides an optimized global network and innovative technology stack, delivering the industry’s #1 managed SD-WAN service and setting the gold standard for application performance. Aryaka’s SmartServices platform offers connectivity, application acceleration, security, cloud networking and insights that leverage global orchestration and provisioning. The company’s customers include hundreds of global enterprises including several in the Fortune 100.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release

Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye